Descripción de las tasas de mortalidad por cáncer gástrico como causa básica entre los años 2017 a 2021 en Chile / Description of death rates due to gastric cancer as a basic cause between 2017 and 2021 in Chile

Introducción: El cáncer gástrico, en Chile, ocupa el primer lugar como causa de mortalidad por tumores malignos, por ello, es de suma importancia conocer la descripción demográfica de esta enfermedad en el país. El periodo en estudio 2017-2021 entrega información actualizada a la salud pública. Metodología: Estudio ecológico, observacional, transversal y descriptivo sobre defunciones por cáncer gástrico en el periodo 2017-2021 en Chile según sexo, grupo etario y regiones (n=15350). Se calculó la tasa de mortalidad (TM). Información obtenida del Departamento de Estadística e Información de Salud e Instituto Nacional de Estadísticas, por lo que no requiere comité de ética. Resultados: Durante el periodo 2017-2021 la TM general fue de 21,84, siendo 21,58 en hombres y 10,68 en mujeres. En edad, el mayor valor se presentó en el grupo de 80 y más años y el menor valor en el grupo de 15-19 años. La TM del periodo general más alta la obtuvo la Región Metropolitana. Discusión: Se evidenció una reducción de la TM entre los años 2017-2021, pudiéndose deber al aumento de tamizaje y tratamiento de Helicobacter pylori. Además, se observó que la TM es mayor en hombres, explicado por su mayor susceptibilidad genética a desarrollar cáncer. La menor TM se registró entre 15-19 años, y la mayor en el grupo 80 y más años, lo que concuerda con literatura internacional. Conclusión: Se necesitan más estudios nacionales para ahondar en los resultados encontrados que permitan darle continuidad a la investigación, y que determinen factores de riesgo específicos de la población chilena.

Introduction: Gastric cancer in Chile takes the first place as a cause of mortality from malignant tumors, therefore it is relevant to know the demographic description of this disease in the country. Studied years go from 2017-2021 in order to get updated data to the Chilean public health. Methodology: Ecological, observational, cross-sectional and descriptive study on deaths due to gastric cancer in 2017-2021 in Chile, according to sex, age group and regions (n=15350). The death rate was calculated. Data was obtained from the Department of Statistics and Health Information and the National Institute of Statistics. It did not require approval from an ethics committee. Results: During the 2017-2021 period the overall death rate was 21.84, 21,58 for men and 10,68 for women. The highest values were in the 80 and older age group and the lowest values in the 15-19 years age group. The highest death rate overall period was registered in the Metropolitan Region. Discussion: There was a reduction in the hospital death rate between 2017-2021, which could be due to the increase in screening and treatment of Helicobacter pylori. Death rate is higher in men, which could be explained because they are more genetically susceptible to developing cancer. The lowest values for death rate were found in the 15-19 years age group, and the highest values in the 80 years and older group, which is consistent with international literature. Conclusion: More studies are required in Chile to broaden the findings to allow investigation continuity and to determine specific risk factors present in the Chilean population.

Delay in Diagnosis of Stomach Cancer Patients Attending a Tertiary CareHospital in Kashmir: A Hospital Based Cross Sectional Study

Introduction: cancers is associated with a favourable outcome. Stomach cancer is one of the most common cancers of gastrointestinal tract. Majority patients visit physicians in developed stages. To evaluate theObjective: reporting pattern of stomach cancer patients living in Kashmir valley in order to determine the median time of delay from the beginning of symptoms to diagnosis. Total 116 proven stomach cancer patientsMethod: were evaluated for the pattern of presentation at endoscopy laboratory of Super Speciality Hospital, Shireen Bagh Kashmir from April 2019 to September 2020. In this study, the mean age (SD) of participantsResults: was 60.22 ± (11.90) years. Majority of the participants (69.8%) were males. Cases were predominantly from the rural area (58%).Only 15.5 % of the cases were diagnosed within one month of their symptoms while as 3.4% of the cases had a total delay of more than 12 months. The study found a considerable total delay in the diagnosis of stomach cancer. The mean of the patient delay was 45.6 days. The median total delay was 20 weeks. Since stomach cancer has high mortality and morbidity rates associated, creatingConclusion: awareness among the population and training of physicians regarding timely referral of patients seems important

Survival in stomach cancer: analysis of a national cancer information system and a population-based cancer registry in Colombia

Background: Stomach cancer is among the most frequent, is a leading cause of mortality in low- and middle-income countries. Assessing its survival is important to guide evidence-based health policies. Aims: To estimate stomach cancer survival in Colombia (2014-2019) with data from the National Cancer Information System (NCIS) and in Cali with data from the Cali Population Cancer Registry (RPCC) (1998-2017). Methods: NCIS estimated the overall 3-year net survival for 8,549 people, while RPCC estimated 5-year net survival for 6,776 people. Results: The 3-year net survival was 36.8% (95% CI: 35.5-38.1). Net survival was higher in people with special insurance (61.7%; 95% CI: 44.8-74.8) or third payer (40.5%; 95% CI: 38.7-42.3) than state insurance (30.7%; 95% CI: 28.7-32.8). It was also higher in women and people diagnosed at early stages. Multivariable analysis showed consistency with survival estimations with a higher risk of death in men, people with state insurance, and diagnosed at advanced stages. In Cali, the 5-year net survival remained stable in men during the last 20 years. In women the 5-year net survival in women increased 8.60 percentage points, equivalent to a 50% increase compared to the 1998-2002 period. For 2013-17, it was 19.1% (95%CI: 16.2-22.2) in men, and 24.8% (95% CI: 20.4-29.3) in women. Conclusions: Population survival estimates from the RPCC were lower than those observed in the NCIS. The differences in their methods and scope can explain variability. Nevertheless, our findings could be complementary to improve cancer control planning in the country.

Antecedentes: El cáncer de estómago se encuentra entre los más frecuentes y es una de las principales causas de mortalidad en los países de ingresos bajos y medianos. Evaluar su supervivencia es importante para orientar las políticas de salud basadas en la evidencia. Objetivos: Estimar la supervivencia del cáncer de estómago en Colombia (2014-2019) con datos del Sistema Nacional de Información del Cáncer (NCIS) y en Cali con datos del Registro Poblacional de Cáncer de Cali (RPCC) (1998-2017). Métodos: El NCIS estimó la supervivencia neta a tres años para 8,549 personas y el RPCC la calculó a 5 años para 6,776 personas registradas en sus bases de datos. Resultados: La supervivencia neta a tres años en Colombia fue del 36.8% (IC 95%: 35.5-38.1). La supervivencia neta fue mayor en personas con seguro especial (61.7%; IC 95%: 44.8-74.8) o tercer pagador (40.5%; IC 95%: 38.7-42.3) que el seguro estatal (30.7%; IC 95%: 28.7-32.8). También fue mayor en mujeres y personas diagnosticadas en etapas tempranas. El análisis multivariable mostró consistencia con la estimación de supervivencia con mayor riesgo de muerte en hombres, personas con seguro estatal y diagnosticados en estadios avanzados. En Cali, la supervivencia neta a 5 años se mantuvo estable en los hombres durante los últimos 20 años. En las mujeres aumentó 8.60 puntos porcentuales, equivalente a un aumento del 50% en comparación con el período 1998-2002. Para el período 2013-17 fue 19.1% (IC 95%: 16.2-22.2) en los hombres y 24.8% (IC 95%: 20.4-29.3) en las mujeres. Conclusiones: Las estimaciones de supervivencia del RPCC fueron más bajas que las obtenidas por el NCIS. Las diferencias en sus métodos y alcance pueden explicar la variabilidad. Sin embargo, nuestros hallazgos pueden ser complementarios para mejorar la planificación del control del cáncer en el país..

Spade-Shaped Anastomosis Following a Proximal Gastrectomy Using a Double Suture to Fix the Posterior Esophageal Wall to the Anterior Gastric Wall (SPADE Operation): Case-Control Study of Early Outcomes

PURPOSE: Proximal gastrectomy (PG) is a function-preserving surgery in cases of proximally located early-stage gastric cancer. Because gastroesophageal reflux is a major pitfall of this operation, we devised a modified esophagogastrostomy (EG) anastomosis to fix the distal part of the posterior esophageal wall to the proximal part of the anterior stomach wall to produce an anti-reflux mechanism; we named this the SPADE operation. This study aimed to show demonstrate the clinical outcomes of the SPADE operation and compare them to those of previous PG cases.MATERIALS AND METHODS: Case details of 56 patients who underwent PG between January 2012 and March 2018 were retrospectively reviewed: 30 underwent conventional esophagogastrostomy (CEG) anastomosis using a circular stapler, while 26 underwent the SPADE operation. Early postoperative clinical outcome-related reflux symptoms, endoscopic findings, and postoperative complications were compared in this case–control study.RESULTS: Follow-up endoscopy showed more frequent reflux esophagitis cases in the CEG group than in the SPADE group (30% vs. 15.3%, P=0.19). Similarly, bile reflux (26.7% vs. 7.7%, P=0.08) and residual food (P=0.01) cases occurred more frequently in the CEG group than in the SPADE group. In the CEG group, 13 patients (43.3%) had mild reflux symptoms, while 3 patients (10%) had severe reflux symptoms. In the SPADE group, 3 patients (11.5%) had mild reflux symptoms, while 1 had severe reflux symptoms (absolute difference, 31.8%; 95% confidence interval, 1.11–29.64; P=0.01).CONCLUSIONS: A novel modified EG, the SPADE operation, has the potential to decrease gastroesophageal reflux following a PG.

An age-period-cohort analysis of mortality rates for stomach, colorectal, liver, and lung cancer among prefectures in Japan, 1999-2018

BACKGROUND@#Although change in the birth cohort effect on cancer mortality rates is known to be highly associated with the decreasing rates of age-standardized cancer mortality rates in Japan, the differences in the trends of cohort effect for representative cancer types among the prefectures remain unknown. This study aimed to investigate the differences in the decreasing rate of cohort effects among the prefectures for representative cancer types using age-period-cohort (APC) analysis.@*METHODS@#Data on stomach, colorectal, liver, and lung cancer mortality for each prefecture and the population data from 1999 to 2018 were obtained from the Vital Statistics in Japan. Mortality data for individuals aged 50 to 79 years grouped in 5-year increments were used, and corresponding birth cohorts born 1920-1924 through 1964-1978 were used for analysis. We estimated the effects of age, period, and cohort on each type of mortality rate for each prefecture by sex. Then, we calculated the decreasing rates of cohort effects for each prefecture. We also calculated the mortality rate ratio of each prefecture compared with all of Japan for cohorts using the estimates.@*RESULTS@#As a result of APC analysis, we found that the decreasing rates of period effects were small and that there was a little difference in the decreasing rates among prefectures for all types of cancer among both sexes. On the other hand, there was a large difference in the decreasing rates of cohort effects for stomach and liver cancer mortality rates among prefectures, particularly for men. For men, the decreasing rates of cohort effects in cohorts born between 1920-1924 and 1964-1978 varied among prefectures, ranging from 4.1 to 84.0% for stomach cancer and from 20.2 to 92.4% for liver cancers, respectively. On the other hand, the differences in the decreasing rates of cohort effects among prefectures for colorectal and lung cancer were relatively smaller.@*CONCLUSIONS@#The decreasing rates of cohort effects for stomach and liver cancer varied widely among prefectures. It is possible that this will influence cancer mortality rates in each prefecture in the future.

Follow-up of Gastrectomized Patients due to Gastric Cancer in a Cancer Center of Bogota, Colombia / Seguimiento de pacientes gastrectomizados por cáncer gástrico en un centro oncológico de Bogotá, Colombia / Seguimento de pacientes gastrectomizados por câncer gástrico em um centro de oncológico em Bogotá, Colômbia

ABSTRACT Objective: To determine the perceived burden and functional status of gastric cancer patients with gastrectomy in a center of cancer in Bogota (Colombia) between 2013 and 2016. Materials and methods: Retrospective description of patients intervened by gastrectomy distributed in three groups: Patients with gastrectomy from 1 to 12 months of surgical intervention, 13 to 14 months and 25 to 36 months. For this, it was used the disease burden perception instrument and the Karnofsky scale. Results: 127 patients were included. 63 from 1 to 12 months, 43 from 13 to 24 months, and 21 from 25 to 36 months of intervention. Gastric adenocarcinoma of intestinal pattern stage III and II predominate. More than 50 % of the patients required total gastrectomy and received adjuvant chemotherapy. The majority of participants performed regular activities with mild signs and symptoms, presented low overall perceived burden and functional performance without statistically significant differences between groups. Patients from 1 to 12 months of intervention reported greater levels of physical discomfort. Conclusions: In patients with gastrectomy for gastric cancer, physical symptoms persist such as emotional disturbances, economic difficulties and limitations in the work role, findings to be included in follow-up programs.

RESUMEN Objetivo: evaluar el seguimiento de pacientes gastrectomizados por cáncer gástrico en un centro de oncología en Bogotá, entre 2013 y 2016, y determinar el estado funcional y la percepción de la carga de enfermedad. Material y métodos: descripción retrospectiva de pacientes intervenidos por gastrectomía, distribuidos en tres grupos: de 1 a 12 meses de seguimiento luego de la intervención, de 13 a 14 meses, y de 25 a 36 meses. Se utilizó un instrumento de percepción de carga de enfermedad crónica validado y la escala de Karnofsky. Resultados: se incluyeron 127 pacientes: 63 a un año, 43 a 2 años y 21 a 3 años. Predomina el adenocarcinoma gástrico de patrón intestinal. Más del 50 % requirió gastrectomía total, más quimioterapia adyuvante, y estaba en estadios II y III. La mayoría realiza actividad normal con signos y síntomas leves, con una carga de enfermedad percibida global baja y un estado funcional sin diferencias significativas entre los grupos. Los pacientes con seguimiento de 1 a 12 meses reportaron un mayor malestar físico. Conclusiones: en pacientes gastrectomizados por cáncer gástrico, persisten síntomas físicos, alteraciones emocionales, dificultades económicas y limitación en el rol laboral, hallazgos por ser incluidos en los programas de seguimiento.

RESUMO Objetivo: Avaliar o seguimento de pacientes gastrectomizados emum centro de referêncianacidade de Bogotá entre 2013 e 2016, determinando o status funcional e a percepção da carga da doença. Material e métodos: Descriçãoretrospropectiva dos pacientes intervencionados por gastrectomiadistribuídosemtrês grupos, que têm entre 1 a 12 meses de intervençãocirúrgica, 13 a 14 meses e 25 a 36 meses. Utilizamos o instrumento de percepção da carga de doençascrônicas, desenhado, avaliado e a escala de Karnofsky. Resultados: 127 pacientes foramacompanhados por gastrectomia por câncer gástrico; 63 emum ano, 43 em 2 anos e 21em 36 meses. Do ponto de vista histopatológico, predomina o adenocarcinoma gástrico intestinal. Mais de 50 % necessitaram de gastrectomia total, além de quimioterapia adjuvante e corresponderamaosestágios II e III. A maioria dos pacientes commonitorizaçãoactividade normal realizada sinais e sintomas leves comumabaixa carga global percebida e um estado funcional, semdiferenças significativas entre os grupos namonitorização de doentesacompanhados durante 1 a 12 meses relatados maisdesconforto físico. Conclusões: Nos pacientes gastrectomizados por câncer gástrico, a percepção de sobrecarga da doença é baixa. Alguns sintomas físicos persistem, disturbios emocionais e dificuldades econômicas, bem como limitação no papel do trabalho, achados a serem considerados no desenvolvimento de programas de acompanhamento.

Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer

BACKGROUND: Low-molecular-weight heparin (LMWH) is the standard treatment for venous thromboembolism (VTE) in patients with active cancer. However, use of factor Xa inhibitors, such as rivaroxaban, is increasing on the basis of limited clinical evidence. The present single-center study compared the incidence of bleeding and other treatment outcomes in gastrointestinal and pancreatobiliary cancer (GI tract cancer) patients administered rivaroxaban or LMWH for the treatment of VTE. METHODS: Retrospective data from 281 GI tract cancer patients who were treated for VTE with rivaroxaban (n = 78) or LMWH (n = 203) between 1 January 2012 and 31 December 2016, were analyzed. Primary end-point was the incidence of major and clinically relevant bleeding. Secondary outcomes included the incidence of recurrent VTE and mortality. RESULTS: Clinically relevant bleeding occurred in 19 patients (24.4%) in the rivaroxaban group and 31 (15.3%) in the LMWH group (P = 0.074). No inter-group difference was observed for rate of VTE recurrence (3.8% with rivaroxaban vs. 3.9% with LMWH; P > 0.999) or incidence of major bleeding (5.1% with rivaroxaban vs. 8.9% with LMWH; P = 0.296). Multivariate Cox proportional hazards analysis for age, cancer type, metastasis, history of chemotherapy or recent surgery, and Eastern Cooperative Oncology Group performance status revealed a 1.904-fold higher risk of bleeding with rivaroxaban than LMWH (1.031–3.516; P = 0.040). No significant inter-group difference was found in terms of hazard ratio for all-cause mortality. CONCLUSION: Compared to LMWH, rivaroxaban was associated with a higher incidence of clinically relevant bleeding in GI tract cancer patients presenting with VTE.

Dynamic Contrast-Enhanced Ultrasound of Gastric Cancer: Correlation with Perfusion CT and Histopathology

OBJECTIVE: To assess the relationship between contrast-enhanced ultrasound (CEUS) parameters and perfusion CT (PCT) parameters of gastric cancers and their correlation with histologic features. MATERIALS AND METHODS: This prospective study was approved by our Institutional Review Board. We included 43 patients with pathologically-proven gastric cancers undergoing CEUS using SonoVue® (Bracco) and PCT on the same day. Correlation between the CEUS parameters (peak intensity [PI], area under the curve [AUC], rise time [RT] from 10% to 90% of PI, time to peak [TTPUS], and mean transit time [MTTUS]) and PCT parameters (blood flow, blood volume, TTPCT, MTTCT, and permeability surface product) of gastric cancers were analyzed using Spearman's rank correlation test. In cases of surgical resection, the CEUS and PCT parameters were compared according to histologic features using Mann-Whitney test. RESULTS: CEUS studies were of diagnostic quality in 88.4% (38/43) of patients. Among the CEUS parameters of gastric cancers, RT and TTPUS showed significant positive correlations with TTPCT (rho = 0.327 and 0.374, p = 0.045 and 0.021, respectively); PI and AUC were significantly higher in well-differentiated or moderately-differentiated tumors (n = 4) than poorly-differentiated tumors (n = 18) (p = 0.026 and 0.033, respectively), whereas MTTCT showed significant differences according to histologic types (poorly cohesive carcinoma [PCC] vs. non-PCC), T-staging (≤ T2 vs. ≥ T3), N-staging (N0 vs. N-positive), and epidermal growth factor receptor expression (≤ faint vs. ≥ moderate staining) (p values < 0.05). CONCLUSION: In patients with gastric cancers, CEUS is technically feasible for the quantification of tumor perfusion and may provide correlative and complementary information to that of PCT, which may allow prediction of histologic features.

CAG PATHOGENICITY ISLAND OF Helicobacter pylori AND ITS ASSOCIATION TO PRENEOPLASTIC LESIONS AND GASTRIC CANCER / EL ISLOTE DE PATOGENICIDAD CAG DE Helicobacter pylori Y SU ASOCIACIÓN CON LESIONES PRENEOPLÁSICAS Y CÁNCER GÁSTRICO

ABSTRACT Gastric cancer is one of the main causes of death by cancer in the world and the infection with Helicobacter pylori is one of the main risk factors associated with its appearance. Helicobacter pylori is a bacterium that colonizes the gastric mucosa, infecting about half of the world´s population. The pathological effects caused by infections with H. pylori greatly depend on an IV type secretion system encoded in the cag pathogenicity island (cagPAI). In this review, we describe the composition of the cagPAI, the alterations of cellular signaling pathways mediated by cagPAI which regulate oncogenic cellular responses that may increase the risk of malignant transformation associated with the infection and the importance of polymorphisms in cagPAI genes as potential markers of progression to gastric cancer.

RESUMEN El cáncer gástrico es una de las principales causas de muerte por cáncer en el mundo y la infección con Helicobacter pylori es uno de los principales factores de riesgo, asociados a su aparición. H. pylori es una bacteria que coloniza la mucosa gástrica, infectando alrededor de la mitad de la población mundial. Los efectos patológicos ocasionados por la infección con H. pylori dependen, en buena parte, de un sistema de secreción tipo IV, codificado en el islote de patogenicidad cag (cagPAI). En esta revisión, se describe la composición del cagPAI, la alteración de las vías de señalización celular mediadas por el cagPAI, que regulan respuestas celulares oncogénicas, que pueden incrementar el riesgo de transformación maligna asociada a la infección y la importancia de los polimorfismos en genes del cagPAI, como posibles marcadores de progresión a cáncer gástrico.

Helicobacter pylori, úlcera péptica y cáncer gástrico / Helicobacter pylori, peptic ulcer and gastric cancer

Resumen Introducción. Por lo general, se ha descrito que la localización duodenal de la úlcera es más frecuente que la localización gástrica; sin embargo, en áreas con alta incidencia de cáncer gástrico la úlcera péptica parece tener una distribución anatómica distinta, existiendo predominio de la localización gástrica. Objetivo. Realizar una revisión narrativa de la literatura acerca de la distribución anatómica de la úlcera péptica en áreas con alta y baja incidencia de cáncer gástrico. Materiales y métodos. Se realizó una búsqueda estructurada de la literatura en las bases de datos ProQuest, EBSCO, ScienceDirect, PubMed, LILACS, Embase, Trip, SciELO y Cochrane Library con los términos "Peptic ulcer" AND "stomach neoplasm"; la búsqueda se hizo en inglés con sus equivalentes en español y se limitó a estudios observacionales, cohortes y casos y controles. Resultados. Se encontraron alrededor de 50 artículos con información relevante para la presente revisión. Conclusión. La literatura disponible sugiere que la úlcera péptica predomina en áreas donde el cáncer gástrico tiene alta incidencia, mientras que en zonas donde la incidencia de la neoplasia es baja predomina la localización duodenal.

Abstract Introduction: In general, ulcers are more frequently observed in the duodenum than in the stomach. However, in areas with a high incidence of gastric cancer, peptic ulcers seem to have a different anatomical distribution, predominantly gastric localization. Objective: To perform a narrative literature review about the anatomical distribution of peptic ulcers in areas with high and low incidence of gastric cancer. Materials and methods: A structured literature search was performed in the ProQuest, EBSCO, ScienceDirect, PubMed, LILACS, Embase, Trip, SciELO and Cochrane Library databases using the terms "Peptic ulcer" AND "Stomach Neoplasm". The search was done in English with its equivalents in Spanish and was limited to observational studies, cohorts and cases and controls. Results: About 50 articles with relevant information for this review were retrieved. Conclusion: The available literature suggests that peptic ulcers predominate in areas where gastric cancer has a high incidence, while duodenal localization predominates in areas where the incidence of neoplasms is low.

Study Of Haematological And Coagulation Profile In Patients With Gastrointestinal Malignancies

Background: Gastrointestinal (GI) Malignancy is one of the commonest malignancies encountered in developing countries. The goal of this study was to analyze the haematological and coagulation profile- Complete Blood Count (CBC), Prothrombin time (PT), activated partial thromboplastin time (aPTT) among patients of gastrointestinal malignancies. Materials and Methods: Fresh blood samples were collected from the diagnosed patients with appropriate anticoagulant in proper proportion. Complete blood count was done by automated analyzer. Peripheral blood smear was seen in cases with abnormal results on CBC. Peripheral smears were stained with Leishman’s stain using standard procedures and then examined under light microscope. Results: A total of 30 patients with gastrointestinal malignancy were included in this study. There were 19 males and 11 females. Among all cases of gastrointestinal malignancy, stomach cancers constitute the maximum (50%) followed by rectal cancers accounting for 23.3%. GI malignancy had negative impact on haemoglobin profile, affecting 56.6% of cases. In peripheral smear study, microcytic hypochromic anaemia was most common comprising 63.3% of cases. Regarding leukocyte count, 16(53.3%) cases had leukocytosis,07 have normal leukocyte count,7 had leukopenia. Out of 30 cases, 56.6% had normal thrombocyte count, 30% had thrombocytopenia and 13.3% had thrombocytosis. Out of 30 cases, 60% cases had the normal prothrombin time and 40% cases had values higher than the reference value. Regarding activated partial thromboplastin time (aPTT), 63.3% cases had normal reports and 36.6% cases had values higher than the reference value. Conclusion: Reduced haemoglobin, increase in neutrophil count, change in coagulation profile are associated with poor prognosis in patients with GI malignancy. Hence close monitoring of haematological and coagulation profile in patients with gastrointestinal malignancy will help in reducing morbidity and mortality.

Effects of different injection methods of nanocarbon tracer on gastrectomy for patients with gastric cancer / 中华消化内镜杂志

Objective To discuss effects of different injection methods of nanocarbon tracer on gastrectomy for patients with gastric cancer. Methods Patients, who underwent D2 gastrectomy in Fuzhou General Hospital from January 2014 to December 2015, were randomly divided into group A and group B. The patients in group A were injected with nanocarbon into gastric submucosa of peripheral area of tumor under gastroscope 24 hours before operation. The patients in group B were injected with normal saline firstly, and then injected with nanocarbon. The operations were performed by 5 high qualification physicians and 3 low qualification physicians. The detection of lymph nodes and black stain nodes,detection time,and lymph node metastatic rate were compared between the two groups.Results A total of 248 patients were enrolled in this study,and each group had 124 cases. There was no statistical difference on basic characteristics between the two groups(P>0.05). A total of 2 975 and 3 855 lymph nodes were detected in group A and group B, respectively. The mean number of detected lymph nodes in group A was significantly lower than that of group B(23.9±7.9 VS 31.1±3.6, P=0.00). The rate of black stain nodes in group A was significantly lower than that of group B[71.3%(2 121/2 975)VS 78.1%(3 011/3 855), P= 0.00].There were no statistical differences on lymph node detection time(24.3±5.7 min VS 23.5±6.2 min), tiny lymph node detection rate(33.1% VS 34.9%),and lymph node metastatic rate(27.3% VS 25.8%)between the two groups(P>0.05).In subgroup of low qualification physicians, the number of lymph nodes(16.9± 4.0 VS 30.1±3.7)and the rate of black stain nodes(61.3% VS 77.2%)in group A were significantly lower than those of group B(P<0.05). The corresponding indicators(31.1±3.3 VS 31.5±3.5,76.8% VS 79.0%) had no statistical differences in the subgroup of high qualification physicians(P>0.05). Conclusion For low qualification physicians, injection of normal saline then of nanocarbon into gastric submucosa under gastroscope could improve lymph node and black stain nodes detection rate for patients with gastric cancer on gastrectomy.

Changes and significance of serum NGAL ,COX-2 and PG in patients with gastric cancer / 国际检验医学杂志

Objective To study the changes and significance of serum neutrophil gelatinase associated li-pocalin (NGAL ) ,cyclooxygenase 2 (COX-2 ) and pepsinogen (PG ) in the patients with gastric cancer . Methods Sixty cases of gastric cancer in this hospital from April 2015 to April 2017 were selected as the ob-servation group ,and contemporaneous 60 healthy subjects were selected as the control group .The double-anti-body sandwich enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of serum NGAL , COX-2 ,PGⅠ ,PG Ⅱ and PG Ⅰ /PGⅡ (PGR) in the two group .The results were compared .The relationship between serum NGAL and COX-2 with the clinicopathological parameters of gastric cancer was analyzed . Results The levels of serum NGAL and COX-2 in the observation group were (23 .43 ± 8 .34)ng/mL and (41 .44 ± 9 .51)ng/mL respectively ,which were higher than (11 .73 ± 2 .81)ng/mL and (16 .89 ± 6 .26)ng/mL in the control group ,the difference was statistically significant (P<0 .05) .Serum PGⅠ and PGR levels in the observation group were(13 .07 ± 20 .19)ng/mL and (2 .69 ± 1 .41) ,which were lower than (60 .15 ± 18 .70) ng/mL and (5 .08 ± 1 .86) in the control group ,the difference was statistically significant (P<0 .05) .The ser-um NGAL level in the patients with TNM stage Ⅰ + Ⅱwas significantly lower than that in the patients with TNM stage Ⅲ + Ⅳ ,the difference was statistically significant (P<0 .05);the serum NGAL level in the pa-tients with distant metastasis was significantly higher than that in the patients without distant metastasis ,the difference was statistically significant (P<0 .05) .The serum COX-2 level in the patients with TNM stage Ⅰ +Ⅱwas significantly lower than that in the patients with TNM stage Ⅲ + Ⅳ ,the difference was statistically sig-nificant(P<0 .05) .Conclusion Serum NGAL ,COX-2 and PG can serve as the effective indicators for gastric cancer screening ,disease condition judgment and prognosis assessment in gastric cancer .

Current Methods of Circulating Tumor Cell Detection / 대한Helicobacter연구학회지

Liquid biopsy, the analysis of circulating biomarkers from peripheral blood, such as circulating tumor cells (CTCs) and circulating tumor DNA, and exosomes, offers a less invasive, new source of cancer-derived materials that may reflect the status of the disease better and thereby contribute to personalized treatment. Recent advances in microfluidics and molecular analysis technologies have resulted in greatly improved CTC enumeration and detection. In this article, we review commercially available technologies used to isolate CTCs from peripheral blood, including immunoaffinity and label-free, physical property-based isolation methods. Although enormous technological progress has been made, especially within the last decade, only a few CTC detection methods have been approved for routine clinical use. Here, we provide an overview of the current CTC isolation methods and examples of their potential application for early diagnosis, prognosis, treatment monitoring, and prediction of resistance to cancer therapy. Furthermore, the challenges that remain to be addressed before such tools are implemented for routine use in clinical settings are discussed.

Desigualdades en mortalidad relacionadas con características socioeconómicas en el departamento del Huila, Colombia 2009-2013 / Inequalities in mortality related to socioeconomic characteristics in the department of Huila, Colombia 2009-2013 / Desigualdades na mortalidade relacionadas a características socioeconômicas no departamento de Huila, Colômbia 2009-2013

Resumen Objetivo: determinar las desigualdades en la mortalidad por causas específicas relacionadas con características socioeconómicas, en municipios del Huila 2009-2013. Métodos: estudio ecológico que comparó las mortalidades por Infección Respiratoria Aguda, cáncer de estómago, enfermedades hipertensivas y cerebrovasculares, accidentes de tránsito, homicidio, diabetes y mortalidad en niñez, con base en su situación socioeconómica, según las variables socioeconómicas Cobertura en Educación Media, NBI, Ruralidad, Suficiencia Económica, Valor Agregado Municipal y el Índice de Calidad del Agua en los 37 municipios del Huila. Se calcularon tasas ajustadas por edad con el método directo y medición de desigualdades confrontando las variables descritas, usando medidas basadas en rango, regresión y desproporcionalidad, usando el software Epidat 4.0. Resultados: en la mortalidad por cáncer gástrico, por enfermedades hipertensivas y en la mortalidad en niñez se identificó constante desigualdad frente a las variables socioeconómicas evaluadas, en contra de los municipios menos favorecidos. En la mortalidad por infecciones respiratorias agudas y homicidios, se observaron mayores tasas en los municipios con mejores condiciones socioeconómicas. Conclusiones: existe gran variabilidad entre las condiciones socioeconómicas de los municipios y entre las mortalidades por los eventos evaluados, observando aceptable correlación entre las diferentes medidas de desigualdades utilizadas.

Abstract Objective: to determine the inequalities in mortality due to specific causes related to socioeconomic characteristics in the municipalities of the Huila department, Colombia between 2009 and 2013. Methodology: an ecological study comparing mortality rates due to acute respiratory infection, stomach cancer, hypertensive and cerebrovascular disease, traffic accidents, homicide, diabetes and childhood mortality based on socioeconomic status according to the following socioeconomic variables: secondary education coverage, unsatisfied basic needs, rurality, economic sufficiency, municipality's added value and water quality index. The study included the 37 municipalities of the Huila department. Age-adjusted rates were calculated using the direct method and the inequalities were measured by comparing against the described variables using rank, regression and disproportionality based measures. The Epidat 4.0 software was used for this purpose. Results: child mortality and mortality due to gastric cancer and hypertensive disease showed constant inequality regarding the assessed socioeconomic variables in the less favored municipalities. As for mortality due to acute respiratory infections and homicides, higher rates were observed in municipalities with better socioeconomic conditions. Conclusions: there is great variability in the socioeconomic conditions of the municipalities and the mortality rates due to the assessed events. The authors observed an acceptable correlation between the different measures of inequality used in the study.

Resumo Objetivo: Determinar as desigualdades na mortalidade por causas específicas relacionadas a características socioeconômicas nos municípios de Huila entre os anos de 2009 e 2013. Metodologia: Estudo ecológico que comparou as mortalidades por infecção respiratória aguda, câncer de estômago, doenças hipertensivas e acidentes vasculares cerebrais, acidentes de trânsito, homicídio, diabetes e mortalidade na infância com base na situação socioeconômica segundo as variáveis socioeconômicas cobertura do ensino médio, NBI, Ruralidade, Suficiência Econômica; Valor Agregado Municipal e o Índice de Qualidade da Água nos 37 municípios de Huila. Foram calculadas as taxas ajustadas por idade com o método direto e a medição de desigualdades, confrontando-as com as variáveis descritas, a partir da utilização de medidas baseadas no intervalo, em regressão e em desproporcionalidade, utilizando-se o software Epidat 4.0. Resultados: Na mortalidade por câncer gástrico, por doenças hipertensivas e na mortalidade na infância foram identificadas constantes desigualdades em relação às variáveis socioeconômicas avaliadas contrárias aos municípios menos favorecidos. Para a mortalidade por infecções respiratórias agudas e homicídios, foram observadas maiores taxas nos municípios com melhores condições socioeconômicas. Conclusões: Existe uma grande variedade entre as condições socioeconômicas dos municípios e entre as mortalidades para os eventos avaliados, observando-se uma correlação aceitável entre as diferentes medidas de desigualdade utilizadas.

Static absorption compound anesthesia with intravenous anesthesia alone stress reaction and cellular immune function with gastric cancer surgery / 中国现代普通外科进展

Objective:To explore the analysis of the static absorption compound anesthesia with intravenous anesthesia alone stress reaction and cellular immune function in patients with gastric cancer surgery.Methods:From March 2014 to March 2014 were lines of gastric cancer patients,78 cases of elective surgical procedureS,using the random number table method was divided into control group and experimental group,each group of 39 cases,control group given simple intravenous anesthesia,patients given static absorption compound anesthesia,compared two groups of patients with preoperative 30 min (T0),cut the skin (T1),bi (T2),tube drawing immediate (T3),24 h after surgery (T4) different time points,such as serum C-reactive protein (CRP) and interleukin 2 (IL-2),the level of interleukin 8 (IL-8),CD4,CD8,the number of NK cells,and CD4/CD8 ratio.Re· sults:T2 IL-2,IL-8 point test group dropped to the lowest level,CRP rose to the highest,to T4 point back to the level before anesthesia,IL-2 and the control group,while the level of IL-8 T3 point minimum,CRP rose to the highest,and T4 point is still not fully recovered to the level before anesthesia,CRP T1 and T4 each point test group,IL-2 and IL-8 cytokine levels were significantly better than the control group,with significant difference (P＜0.05).T1 point,two groups of patients with CD4,NK cells and CD4/CD8 ratios were significantly decreased,CD8 levels increased significantly,CD4 T3 point test group began to rebound,NK cells and CD4/CD8 ratio,level of CD8 began to decline,and T4 point before anesthesia recovery level,and T4 point control indicators are still relatively preoperative levels have obvious deviation,T1 and T4 each point group CD4,NK cells and CD4/CD8 ratio than the control group obviously on the higher side,had clear statistical significance(P＜0.05),and each point CD8 levels have no obvious difference between groups(P＞0.05).Conelusions:Different anesthetic methods on gastric cancer surgery the patient's level of stress reaction and cell immune function all can produce certain effect,compared with the conventional simple intravenous anesthesia,the static absorption compound anesthesia can obviously relieve open perioperative stress response in patients with gastric cancer,reduce the inhibition of cellular immune level,is a kind of can effectively guarantee the anesthesia effect and prognosis of patients with ideal anesthesia method.

Effect of preoperative chemotherapy with XELOX and psychological intervention on surgical treatment of advanced gastric cancer / 中国生化药物杂志

Objective To investigate the clinical effect of preoperative XELOX chemotherapy combined with psychological intervention on patients with advanced gastric cancer.Methods The control group, advanced gastric cancer patients underwent surgical treatment, XELOX chemotherapy was given before the operation.The study group was treated with psychological intervention on the basis of the treatment of the control group.The clinical efficacy and adverse reactions of two patients with advanced gastric cancer were recorded.Results Study group five years survival rate(63.83%),disease-free survival(42.55%),no advanced end point event probability(46.81%)was significantly higher than the control group(five and 44.68%year survival rate, disease-free survival rate was 23.40%,no advanced end point event probability 27.66%),data comparison study group P<0.05;wound healing reaction indigestion, gastrointestinal reaction, infection, oral mucositis incidence was significantly lower than the control group(P<0.05).Conclusion In the preoperative XELOX chemotherapy combined with surgical treatment on the basis of advanced gastric cancer with the corresponding psychological intervention can effectively improve the curative effect and prognosis,has positive significance to guarantee the quality of life of patients, life safety.

Complications and Survival Rate of Patients Over 80 Years Old Who Underwent Laparoscopic Gastrectomy for Gastric Cancer

PURPOSE: As the life expectancy increases, the population of elderly patients increases. We evaluated the complications and survival rate of patients over 80 years old, who underwent laparoscopic gastrectomy. METHODS: A retrospective analysis was conducted for a total of 1,912 patients, who underwent surgery with stomach cancer from 2008 to 2016. We analyzed postoperative complications and the survival rate between the middle old (70~79, n=255) group and the very old (≥80, n=37) group. RESULTS: Among 1,912 patients, 255 people in the middle old group and 37 people within the very old group underwent laparoscopic gastrectomy. We confirmed that there was no significant difference except for the age (p<0.001) between the two groups. Overall complications were not statistically significantly different between the Middle old (70~79) group and the very old (≥80) group, 11.8% and 16.2%, respectively. There were also no statistically significant differences in severe complications beyond Clavien-Dindo classification Grade III. Risk factors for overall complications were higher in males than in females (p=0.002). Overall survival was statistically significantly lower with very old group (p<0.001). CONCLUSION: Laparoscopic gastrectomy in gastric cancer patients over 80 years of age is feasible and safe in terms of complications. However, considering the life expectancy, it seems necessary to pay attention to the patients who apply surgery.

Disease burden of stomach cancer in the Chinese population, in 1990 and 2013 / 中华流行病学杂志

Objective To analyze the national and provincial disease burden on stomach cancer in the Chinese population,in 1990 and 2013.Methods Data related to province-specific burden of disease in China was used to analyze the standardized incidence and mortality of stomach cancer in 2013.Parameters as incidence,mortality,disability-adjusted life years (DALY),years of life lost due to premature mortality (YLL) and years lived with disability (YLD) on stomach cancer in China in 1990 and 2013,were analyzed while the standardized incidence and mortality of stomach cancer in 1990 and 2013 and the changing patterns in each province were described.Results In 2013,there were 371 100 new cases of stomach cancer and 317 800 cases died from stomach cancer in China.Figures on the standardized incidence (26.84/100 000),mortality rate (23.55/100 000) and DALY rate (464.47/100 000) all increased with age.Between 1990 and 2013,the standardized incidence rates in men were all higher than that in women (2.03-2.67 times) but both showed a decreasing trend.Under the reported figures,317 800 people died from stomach cancer in 2013,with an increase of 13.15％.The number of deaths was 182 700,in 1990.From 1990 to 2013,the standardized mortality rate,DALY and DALY rate decreased in both genders,with more seen in women than in men.The top three provinces that having the highest stomach cancer standardized incidences and mortality in 2013 were Qinghai,Anhui,Gansu.The top three provinces with the most reduction of figures appeared in Tianjin,Shanghai and Zhejiang.Compared with those in 1990,the standardized mortality decreased in all the provinces,in 2013.Conclusions The disease burden of stomach cancer in China remained at high level in 2013.Compared with those in 1990,the disease burden of stomach cancer decreased in 2013.The standardized mortality of stomach cancer in all the provinces had decreased but the provincial differences still existed.

Disease burden of stomach cancer in the Chinese population, in 1990 and 2013 / 中华流行病学杂志

Objective To analyze the national and provincial disease burden on stomach cancer in the Chinese population,in 1990 and 2013.Methods Data related to province-specific burden of disease in China was used to analyze the standardized incidence and mortality of stomach cancer in 2013.Parameters as incidence,mortality,disability-adjusted life years (DALY),years of life lost due to premature mortality (YLL) and years lived with disability (YLD) on stomach cancer in China in 1990 and 2013,were analyzed while the standardized incidence and mortality of stomach cancer in 1990 and 2013 and the changing patterns in each province were described.Results In 2013,there were 371 100 new cases of stomach cancer and 317 800 cases died from stomach cancer in China.Figures on the standardized incidence (26.84/100 000),mortality rate (23.55/100 000) and DALY rate (464.47/100 000) all increased with age.Between 1990 and 2013,the standardized incidence rates in men were all higher than that in women (2.03-2.67 times) but both showed a decreasing trend.Under the reported figures,317 800 people died from stomach cancer in 2013,with an increase of 13.15％.The number of deaths was 182 700,in 1990.From 1990 to 2013,the standardized mortality rate,DALY and DALY rate decreased in both genders,with more seen in women than in men.The top three provinces that having the highest stomach cancer standardized incidences and mortality in 2013 were Qinghai,Anhui,Gansu.The top three provinces with the most reduction of figures appeared in Tianjin,Shanghai and Zhejiang.Compared with those in 1990,the standardized mortality decreased in all the provinces,in 2013.Conclusions The disease burden of stomach cancer in China remained at high level in 2013.Compared with those in 1990,the disease burden of stomach cancer decreased in 2013.The standardized mortality of stomach cancer in all the provinces had decreased but the provincial differences still existed.